| Stem definition | Drug id | CAS RN |
|---|---|---|
| Janus kinase inhibitors, antineoplastics | 5481 | 944118-01-8 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| March 26, 2019 | PMDA | ASTELLAS PHARMA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | L04AA49 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS Selective immunosuppressants |
| MeSH PA | D004791 | Enzyme Inhibitors |
| MeSH PA | D007155 | Immunologic Factors |
| MeSH PA | D007166 | Immunosuppressive Agents |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Rheumatoid arthritis | indication | 69896004 | DOID:7148 |
| Hepatic failure | contraindication | 59927004 | |
| Pregnancy | contraindication | 289908002 |
None
None
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Tyrosine-protein kinase JAK3 | Kinase | INHIBITOR | IC50 | 9.15 | DRUG LABEL | DRUG LABEL | |||
| Tyrosine-protein kinase JAK1 | Kinase | INHIBITOR | IC50 | 8.41 | DRUG LABEL | DRUG LABEL | |||
| Tyrosine-protein kinase JAK2 | Kinase | INHIBITOR | IC50 | 8.30 | DRUG LABEL | DRUG LABEL | |||
| Non-receptor tyrosine-protein kinase TYK2 | Kinase | INHIBITOR | IC50 | 8.32 | DRUG LABEL | DRUG LABEL |
| ID | Source |
|---|---|
| HPH1166CKX | UNII |
| 1353219-05-2 | SECONDARY_CAS_RN |
| C4505522 | UMLSCUI |
| 9T6 | PDB_CHEM_ID |
| CHEMBL3137308 | ChEMBL_ID |
| 57928403 | PUBCHEM_CID |
| DB11708 | DRUGBANK_ID |
| CHEMBL3137329 | ChEMBL_ID |
| 9910 | INN_ID |
| 8315 | IUPHAR_LIGAND_ID |
| D10653 | KEGG_DRUG |
| C000608065 | MESH_SUPPLEMENTAL_RECORD_UI |
None